Abstract
Neoadjuvant hypofractionated radiotherapy combined with pembrolizumab plus chemotherapy for potentially resectable non-small cell lung cancer: A phase Ib study.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have